IMV Inc. (IMVIF)
OTCMKTS · Delayed Price · Currency is USD
0.0020
0.00 (0.00%)
At close: Apr 7, 2026
IMV Inc. Market Cap
IMV Inc. has a market cap or net worth of $29.42 thousand as of April 8, 2026. Its market cap has decreased by -99.88% in one year.
Market Cap
29.42K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 25, 2012, IMV Inc.'s market cap has decreased from 17.18M to 29.42K, a decrease of -99.83%. That is a compound annual growth rate of -36.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 29.42K | 196,053.33% |
| Dec 30, 2024 | 15.00 | -99.94% |
| Dec 29, 2023 | 25.77K | -99.92% |
| Dec 30, 2022 | 30.60M | -69.46% |
| Dec 31, 2021 | 100.21M | -51.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synovics Pharmaceuticals | 36.00 |
| Neurobiological Technologies | 27.00 |
| Anthera Pharmaceuticals | 26.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| Poniard Pharmaceuticals | 15.00 |
| PhaseRx | 12.00 |
| ContraFect | 11.00 |